MeadWestvaco Healthcare Package Wins DuPont Award for Innovation
MeadWestvaco Corporation announces that its Shellpak™ healthcare packaging solution has received a DuPont Silver Award for Innovation in Packaging.
New York, NY – August 10, 2005 – MeadWestvaco Corporation announces that its Shellpak™ healthcare packaging solution has received a DuPont Silver Award for Innovation in Packaging. Shellpak™, made of high-impact, injection-molded polystyrene, was developed to enhance patient compliance while providing the highest levels of child resistance and senior friendliness to patients and consumers.
The DuPont Awards for Innovation in Packaging is an international, independently judged competition that recognizes advances in utilizing plastic packaging materials. The program has attracted hundreds of entries from 33 countries since its inauguration in 1986. The awards focus on innovations in food and non-food packaging solutions, recognizing that new developments result from contributions made at virtually any point in the supply chain, from technology, equipment, printing and graphics to the final end-use package.
Shellpak™ functions as a secondary pharmaceutical package for unit-dose medications – the rigid plastic "shell" construction provides durable protection and child resistance for blister-packed medications and is especially well suited for friable tablets. The package has been designed for in-house fulfillment using standard high speed cartoning equipment.
Shellpak™ can be customized to reflect brand image and provide differentiation for the product it transports, making it an ideal package for new product introductions or revitalizations in the pharmaceutical and consumer health markets.
MeadWestvaco, a leader in healthcare packaging, is on the forefront of applying new combinations of materials and technologies to promote consumer and patient education, safety and compliance while reinforcing product quality and brand image. Shellpak™ is one of a variety of solutions MeadWestvaco offers. Other solutions include Dosepak, the recipient of five prestigious awards, including the 2003 World Star President's Award
For more information about MeadWestvaco Healthcare Packaging, please visit www.MWVhealthcare.com.
About MeadWestvaco Corporation
MeadWestvaco, headquartered in Stamford, Conn., is a global packaging company that delivers high-value packaging solutions and products to the world's most recognized companies in the food and beverage, media and entertainment, personal care, cosmetic and healthcare industries. The company also has market-leading positions in its Consumer & Office Products, Specialty Chemicals and Specialty Papers businesses. MeadWestvaco, with operations in more than 29 countries, has been selected for the Dow Jones Sustainability Indexes, and manages its forestlands in accordance with the Sustainable Forestry Initiative®. For more information, please visit www.meadwestvaco.com
.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
